EXO Therapeutics

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.

Exostemtech

This biotechnology firm develops exosome-based therapeutics and production platforms for clinical researchers and healthcare providers treating intractable diseases.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.

Redona Therapeutics

This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

Eradivir

This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.